Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study
1 other identifier
observational
2,000,000
1 country
1
Brief Summary
Determine the consequences of COVID-19 pandemic on routine targeted surgeries. Five surgical procedures were considered : cataract surgery, hip and knee arthoplasties, coronary revascularisation by angioplasty and definitive cardiac stimulation. The objective of the study is to quantify changes of these procedures in 2020 and in 2021 (up to June) compared to 2019 taking into account their annual evolution and according to the type of operation (primary or reoperation/revision) and emergency status, if applicable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
January 14, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2022
CompletedFebruary 3, 2022
January 1, 2022
2.5 years
January 14, 2022
January 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
observed and expected number
2020 and first half of 2021
Study Arms (5)
- cataract surgery
- hip arthoplasty
- knee arthoplasty
- coronary angioplasty
- definitive cardiac stimulation (pacemaker)
Interventions
number of hospital stays
Eligibility Criteria
All hospitalizations with at least one act of each surgery between January 1, 2019, and June 30, 2021 from the French National Health Data System (SNDS). The National Health Data System (SNDS) is a set of strictly anonymous databases, comprising all mandatory national health insurance reimbursement data, particularly data derived from processing of health care claims (electronic or paper claims) and data from health care facilities (PMSI).
You may qualify if:
- hospitalizations with at least one act of cataract surgey hip arthroplasty knee arthroplasty coronary angioplasty definitive cardiac stimulation (pacemaker)
- between January 1, 2019, and June 30, 2021
You may not qualify if:
- hospitalizations for personal identifier problems in the database
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- EPI-PHARElead
Study Sites (1)
E Dufour
Saint-Denis, Île-de-France Region, 93 285, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mahmoud Zureik
EPI-PHARE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- pharmacoepidemiologist, French National Agency for Medicines and Health Products Safety, French National Health Insurance
Study Record Dates
First Submitted
January 14, 2022
First Posted
January 19, 2022
Study Start
January 1, 2019
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
February 3, 2022
Record last verified: 2022-01